Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia

M Sagud, L Tudor, S Uzun, MN Perkovic… - Frontiers in …, 2018 - frontiersin.org
Treatment-resistant schizophrenia (TRS) continues to be a challenge. It was related to
different factors, including alterations in the activity of brain dopaminergic system, which …

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia

M Nikolac Perkovic, M Sagud, M Zivkovic, S Uzun… - Scientific reports, 2020 - nature.com
Antipsychotic drugs target primarily dopaminergic system which makes catechol-O-
methyltransferase (COMT) an interesting target in studies searching for treatment response …

Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a …

E Huang, CC Zai, A Lisoway… - International Journal …, 2016 - academic.oup.com
Background: The catechol-O-methyltransferase (COMT) enzyme plays a crucial role in
dopamine degradation, and the COMT Val158Met polymorphism (rs4680) is associated with …

[HTML][HTML] Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: An updated meta-analysis

J Ma, M Zhao, W Zhou, M Li, C Huai… - Current …, 2021 - ncbi.nlm.nih.gov
Background Catechol-O-methyltransferase (COMT) contributes to the control of synaptic
dopamine (DA) transmission by catalyzing DA degradation in the presynaptic space. The …

The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on …

TB González-Castro, Y Hernández-Díaz… - Neuromolecular …, 2016 - Springer
An association between a catechol-O-methyltransferase (COMT) Val156Met (rs4680)
polymorphism and schizophrenia has been reported in the literature, although no conclusive …

Association Studies of Catechol-O-Methyltransferase (COMT) Gene with Schizophrenia and Response to Antipsychotic Treatment

M Gupta, P Bhatnagar, S Grover, H Kaur… - …, 2009 - Taylor & Francis
Aim: We investigated the catechol-O-methyltrasferase (COMT) gene, which is a strong
functional and positional candidate gene for schizophrenia and therapeutic response to …

Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the …

P Molero, F Ortuno, M Zalacain… - The Pharmacogenomics …, 2007 - nature.com
Genetic variation in the catechol-O-methyltransferase (COMT) gene may influence the
susceptibility to schizophrenia and the response to neuroleptic treatment. The authors tested …

Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia

TW Park, KS Yoon, JH Kim, WY Park… - European …, 2002 - Elsevier
Genetic polymorphism of catechol-O-methyltransferase (COMT), involved in the degradation
of catecholamine neurotransmitters, has been investigated as a candidate for modifier of …

Meta-analysis of association between genetic variants in COMT and schizophrenia: an update

T Okochi, M Ikeda, T Kishi, K Kawashima… - Schizophrenia …, 2009 - Elsevier
A common functional polymorphism, Val108/158Met (rs4680), and haplotypes rs737865–
rs4680–rs165599 in the Catechol-O-methyltransferase gene (COMT) have been extensively …

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia

J Han, Y Li, X Wang - Neuropsychiatric disease and treatment, 2017 - Taylor & Francis
Objective The current study aimed to explore the association of single nucleotide
polymorphisms (SNPs) within catechol-O-methyltransferase (COMT) and dopamine …